Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Accepts Sarepta's sNDAs for Casimersen and Golodirsen for Duchenne Muscular Dystrophy
2
Gene-Silencing Therapy EPI-321 Shows Early Evidence of Increased Muscle Volume in Phase 1/2 FSHD Study
3
Avalglucosidase Alfa Meets All End Points in Phase 3 Baby-COMET Trial for Infantile-Onset Pompe Disease
4
Monoclonal Antibodies Show Greater Relapse Reduction in AQP4-IgG Seropositive vs Seronegative NMOSD, Meta-Analysis Finds
5